IMWG Recommendations for the prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

This paper, produced by the International Myeloma Working Group, summarises the available evidence and provides recommendations for a prophylaxis strategy according to a risk assessment model, to reduce the risk of a venous thromboembolic event in myeloma patients.